Genetic Testing for Kidney Disease Often Not Discussed
A recent survey revealed that most patients with chronic kidney disease (CKD) are not being informed about genetic testing options by their healthcare providers. Despite the existence of guidelines recommending such discussions, only 1 in 5 patients reported having conversations about genetic testing. Researchers emphasize the importance of increasing awareness and communication regarding genetic testing for kidney diseases among both providers and patients.
- ▪Only 1 in 5 patients with CKD reported discussions about genetic testing with their healthcare providers.
- ▪Between 20% and 30% of CKD cases have a genetic basis, which is often underrecognized.
- ▪Significant predictors for provider discussions included being younger than 50, male, and having private insurance.
Opening excerpt (first ~120 words) tap to expand
New Orleans — Clinicians are not discussing genetic testing or counseling with the majority of patients with chronic kidney disease (CKD) in whom such testing is indicated, a new survey found.Despite guidance published in Kidney International in 2020, and a 2024 report by the National Kidney Foundation (NKF) Genetic Testing Working Group, the survey showed that only 1 in 5 people with CKD in whom genetic testing was indicated reported that a healthcare provider had discussed either genetic testing or counseling with them.“This study highlights the need for more discussion between providers and their patients about genetic testing for kidney disease,” said Radhika Patel, MD, of the Center for Precision Medicine and Genomics at Columbia University Irving Medical Center, New York City, and…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
